SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Cipla informs about press release

18 Jan 2023 Evaluate
Cipla has informed that it enclosed a press release dated 18th January 2023 titled ‘Cipla launches Cippoint – a point-of-care device for non-communicable diseases, infectious diseases, and other health conditions’.

The above information is a part of company’s filings submitted to BSE.

Cipla Share Price

1445.85 14.20 (0.99%)
09-Jul-2026 10:11 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1943.00
Dr. Reddys Labs. 1320.75
Cipla 1445.85
Zydus Lifesciences 1168.00
Lupin 2500.55
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: